Related Experiment Video
Updated: Aug 15, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
p21WAF1/CIP1 gene is inactivated in metastatic prostatic cancer cell lines by promoter methylation
S R J Bott1, M Arya, R S Kirby
1Prostate Cancer Research Centre, Institute of Urology, University College London, London, UK. simonrjbott@doctors.org.uk
Introduction:
p21WAF1/CIP1 may act as a tumour suppressor gene (TSG) and loss of the p21WAF1/CIP1 gene has been reported in several solid tumours. The aim of this study was to see whether p21WAF1/CIP1 was expressed in metastatic prostate cancer cell lines and to determine if there was methylation of the p21WAF1/CIP1 promoter.
Method:
PC3, LNCaP and DU145 metastatic prostate cancer cell lines, 1542NP normal prostate, and RD rhabdomyosarcoma cell lines were cultured in the demethylating agent 5-Aza-2 deoxycytidine (5-Aza-CdR). p21WAF1/CIP1 mRNA expression was analysed by RT-PCR. DNA from untreated cell lines was modified with sodium bisulphite and promoter sequencing was performed.
Results:
p21WAF1/CIP1 was expressed at low or undetectable levels in metastatic prostate cancer cell lines but expression was reactivated by treatment with 5-Aza-CdR. Sequence analysis of the promoter region revealed several sites of methylation at the 5' end of a CpG island in the PC3, LNCaP and DU145 cell line DNA but not in the normal prostate control DNA. Most notably the Sis-inducible element (SEI)-1-a STAT1-binding site, was methylated.
Conclusions:
In this study, we show that p21WAF1/CIP1 expression in metastatic prostate cancer cell lines is enhanced as a result of demethylation of the DNA. Furthermore, several cytosine residues in the promoter region are methylated, including critical binding sites. The inhibition of the STAT1-signalling pathway by methylation of the promoter may inactivate the p21WAF1/CIP1 TSG in prostate cancer.
Insights
Methylation silences the p21WAF1/CIP1 tumor suppressor gene in metastatic prostate cancer. Demethylation reactivates its expression, suggesting a therapeutic target for prostate cancer treatment.
Area of Science:
- Molecular Biology
- Cancer Genetics
- Epigenetics
Background:
- p21WAF1/CIP1 functions as a tumor suppressor gene (TSG).
- Loss of p21WAF1/CIP1 gene expression is observed in various solid tumors.
- Investigating p21WAF1/CIP1 in metastatic prostate cancer is crucial.
Purpose of the Study:
- To determine p21WAF1/CIP1 expression in metastatic prostate cancer cell lines.
- To investigate the methylation status of the p21WAF1/CIP1 promoter in these cell lines.
Main Methods:
- Utilized PC3, LNCaP, and DU145 metastatic prostate cancer cell lines.
- Treated cell lines with the demethylating agent 5-Aza-2 deoxycytidine (5-Aza-CdR).
- Analyzed p21WAF1/CIP1 mRNA expression via RT-PCR and promoter sequencing.
Main Results:
- p21WAF1/CIP1 expression was low/undetectable in metastatic prostate cancer cells but reactivated by 5-Aza-CdR.
- Promoter sequencing revealed methylation at the 5' end of a CpG island in metastatic cell lines.
- Key binding sites, including the Sis-inducible element (SEI)-1-a STAT1-binding site, were methylated.
Conclusions:
- Demethylation enhances p21WAF1/CIP1 expression in metastatic prostate cancer cell lines.
- Methylation of promoter cytosine residues, including critical binding sites, is evident.
- Promoter methylation may inactivate the p21WAF1/CIP1 TSG by inhibiting STAT1 signaling in prostate cancer.
Related Concept Videos
Abnormal Proliferation
Inhibition of Cdk Activity
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Negative Regulator Molecules
